Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial.

MLA

Chen, Si-Ye, et al. “Timing of Postmastectomy Radiotherapy Following Adjuvant Chemotherapy for High-Risk Breast Cancer: A Post Hoc Analysis of a Randomised Controlled Clinical Trial.” European Journal of Cancer, vol. 174, Oct. 2022, pp. 153–64. EBSCOhost, https://doi.org/10.1016/j.ejca.2022.07.023.

APA

Chen, S.-Y., Sun, G.-Y., Tang, Y., Jing, H., Song, Y.-W., Jin, J., Liu, Y.-P., Zhao, X.-R., Song, Y.-C., Chen, B., Qi, S.-N., Tang, Y., Lu, N.-N., Li, N., Fang, H., Li, Y.-X., & Wang, S.-L. (2022). Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial. European Journal of Cancer, 174, 153–164. https://doi.org/10.1016/j.ejca.2022.07.023

Chicago

Chen, Si-Ye, Guang-Yi Sun, Yu Tang, Hao Jing, Yong-Wen Song, Jing Jin, Yue-Ping Liu, et al. 2022. “Timing of Postmastectomy Radiotherapy Following Adjuvant Chemotherapy for High-Risk Breast Cancer: A Post Hoc Analysis of a Randomised Controlled Clinical Trial.” European Journal of Cancer 174 (October): 153–64. doi:10.1016/j.ejca.2022.07.023.